Conquering Diseases

Study Of An Investigational Drug Combination For Multiple Myeloma That Has Returned After Treatment

Description

Seeking adults whose Multiple Myeloma has returned after treatment (Relapsed or Refractory) for a study of an investigational drug combination.

Overview

Participants in this study will be given the investigational drug combination (one as an injection and the other as a daily pill) over 28-day cycles.

What we're hoping for

We are studying the safety of an investigational drug combination for adults with Multiple Myeloma that has returned after treatment (Relapsed or Refractory). One of the drugs is FDA approved and the other has not yet been approved.

Additional Information

ClinicalTrials.gov Identifier: NCT06215118

 Principal Investigator

Muthalagu  Ramanathan, MD

UMass Memorial Health

 Study Contact

The Clinical Research  Center

508-856-2800

clinicaltrialsunit@umassmed.edu

 Location

UMMH Memorial Campus

281 Lincoln St. 

Worcester,MA 01605

508-334-1000